Targeting Chromatin Remodeling for Cancer Therapy

Area of Science:

• Molecular Biology
• Cancer Biology
• Epigenetics

Background:

• Epigenetic alterations dynamically regulate gene expression and are implicated in diseases like cancer.
• These modifications, including DNA methylation and histone modifications, alter chromatin structure without changing the DNA sequence.
• Unlike genetic mutations, epigenetic changes are reversible, presenting therapeutic opportunities.

Purpose of the Study:

• To provide an overview of epigenetic modulations in cancer.
• To discuss recent advances in drug development targeting epigenetic modifications.
• To highlight novel strategies for regulating the epigenome.

Main Methods:

• Genome-wide mapping of epigenetic events like histone modifications and DNA methylation.
• Review of current research on epigenetic drugs and their mechanisms.
• Analysis of preclinical and clinical studies of epigenetic therapies.

Main Results:

• Epigenetic deregulation, such as tumor suppressor gene silencing, is common in cancer.
• Genome-wide epigenetic mapping enhances understanding of cancer progression.
• Epigenetic drugs, including DNMT1 and HDAC inhibitors, show promise in clinical applications.

Conclusions:

• Epigenetic modifications are dynamic and reversible, making them attractive therapeutic targets.
• Epigenetic drugs are being evaluated for chemotherapy sensitization and immune modulation.
• Advances in targeting epigenetic modulators have led to FDA-approved therapies and increased drug development.